radiation therapy, and stereotactic radiosurgery (SRS) 7 · Total resection provides a cure but may be at the cost of profuse intraoperative bleeding and new cranial nerve (CN) deficits. 2, 8 There have been successful reports of Gamma knife radiosurgery (GKRS) in these tumors. 9, 10 In this article, we analyze our experience in the management of these unusual tumors and review the available literature. We have analyzed our experience with both microsurgery and GKRS.
Materials and Methods
This retrospective study included all the cases of CSH who underwent treatment (both microsurgery and GKRS) at our tertiary level referral center during [2007] [2008] [2009] [2010] [2011] [2012] [2013] [2014] [2015] . The clinical data were analyzed retrospectively. The demographic profile, clinical features, radiologic findings, management strategies, postoperative complications, length of hospitalization, and outcome (both immediate and long term) were noted. The pathology of the tumors was reconfirmed via reexamination of the histologic slides. The patient data were divided into two groups: group 1 consisted of patients who underwent microsurgery whereas group 2 consisted of patients who underwent GKRS.
Results
Group A
There were a total of 15 patients (7 males) with a median age of 34 years (range: 17-58 years). The duration of the symptoms varied from 6 to 62 months. Severe headache and involvement of the CNs passing through the CS were the most common presenting symptoms. Five cases presented with diminution of vision, one with hemiparesis, and one with pituitary dysfunction. Detailed patient characteristics have been outlined in ►Table 1. All the patients underwent preoperative computed tomography (CT) and magnetic resonance imaging (MRI) scans. (►Fig. 1A-D) The tumor volume was 29 to 115 cm 3 (median ¼ 64.57 cm 3 ). CT images showed fairly well-defined parasellar lesions, mild to moderately hyperdense in plain scans, with intense homogenous enhancement. On MRI, CSH were well-delineated parasellar lesions, hypo-to isointense in T1-weighted images and brightly hyperintense in T2-weighted images. Gradient-echo sequences were used to identify any hemorrhagic component, which was seen in two of the cases. Most lesions showed intense homogenous enhancement. In one case in which the enhancement was poor on immediate imaging, delayed imaging showed intense enhancement. This finding is also characteristic of CSH. The characteristic imaging finding following contrast administration was a nipple-like projection of tumor toward sella, which was seen in all cases. In all but five cases, internal carotid artery (ICA) was seen encased within the tumor mass without affecting the vessel diameter. Digital subtraction angiography (DSA) was performed in three cases. The characteristic DSA finding was lack of tumor blush in capillary phase and pooling of contrast in late venous phase, seen in all cases. A prominent meningohypophyseal (inferolateral trunk) branch of cavernous ICA was seen in nine cases. All patients underwent a frontotemporal craniotomy along with an orbitozygotomy (FTOZ) and tumor excision. The sphenoid ridge was drilled, the superior orbital fissure opened, and the anterior clinoid process (ACP) removed extradurally. An extradural temporopolar approach was used in 13 patients whereas a combined extraduralintradural (ED þ ID) was performed in 2 patients. The middle meningeal artery was identified, coagulated and cut at the foramen spinosum. The V2 and V3 branches were exposed, and then an interdural approach to the CS was used. This involved peeling away the outer membranous dural layer from the inner membranous layer using a combination of sharp and blunt dissection. This leads to the lateral wall of CS where the nerves (III, IV, and V1) are exposed. The tumor bulge was clearly made out and the tumor could be accessed between these nerves. As these tumors were highly vascular, they were decompressed rapidly using a Cavitron ultrasonic suction aspirator (CUSA). Feeders from the meningohypophyseal trunk of the intracavernous ICA were exposed and coagulated early in the course of the surgery (►Fig. 2A, B). Care was taken to recognize and prevent injury to the ICA and the VI CN. Once the tumor was removed, including the part medial to the ICA, hemostasis was achieved relatively easily using degraded cellulose (Surgicel, Johnson & Johnson Medical Ltd., New Yorkshire, United Kingdom). The keys to good hemostasis were gross total excision and devascularization at an early stage. In one of our cases, blood loss was profuse the moment tumor decompression was started. In this case, the procedure was abandoned, and DSA was done to look for tumor blush and rule out any associated aneurysm. Following this, gross total resection (GTR) was performed at reexploration'.
GTR or near-total resection (NTR) (i.e., > 95% of tumor removal) was attained in 13 cases. Histopathology in all cases was confirmatory of cavernous hemangiomas (►Fig. 3A, B). Though there was no mortality, morbidity was encountered in 12 cases. These included worsening of extraocular movement (EOM) in 11 cases, hemiparesis in 1 case, and wound infection in 1 case. In the patient with hemiparesis, there was a postoperative hematoma with brainstem compression. However, as the patient was well preserved, it was managed conservatively and the patient gradually and completely improved at follow-up. Among the 15 patients, 5 developed complete ophthalmoplegia. Among these, two showed partial improvement whereas three remained without any improvement. Five patients had transient and partial ophthalmoplegia and all improved at follow-up. Fourteen patients were available for a detailed follow-up. The followup duration varied from 6 to 62 months (mean ¼ 29.4 months). Postoperative MRI was obtained at 3 to 6 months after surgery and then at 6-month intervals. Two cases showed recurrence/residual lesion. In one of them, GKRS was administered, and in the other, in view of the large remnant, resurgery has been advised. In the others, there has been no recurrence or significant increase in size of residual lesions. Abbreviations: EOM, extraocular movement; F, female; GTR, gross total resection; M, male; NTR, near-total resection.
Group B
GKRS was administered as in eight patients (six primary and two residual tumors). It was performed using the Model 4C machine (Elekta, Sweden). The Leksell Stereotactic frame (Elekta, Sweden) was fixed on all patients. An MRI of the brain was performed (1-mm sequences, axial T1-weighted images pre-and postgadolinium contrast). Treatment was planned with an aim of maximal coverage, maximal conformity, and protection of optic pathways (< 8 Gy 
Clinical Presentation
Clinical presentations are usually in the form of acute and subacute dysfunction of the CNs traversing the CS and the optic nerve. The onset is usually insidious and gradual. In contrast to intracerebral hemangiomas, CSHs do not have the propensity to bleed. 2, 14 In our series, two cases had evidence of asymptomatic bleed on radiology. In large tumors, visual deficits and field defects are encountered. In our series, most Another unusual finding in our series was pyramidal weakness in one patient.
Radiology
CSH is the only lesion that is purely intracavernous; thus, even giant lesions remain within the dural confines of the CS. Large CSHs usually extend toward the sella, superior orbital fissure, and Meckel's cave-this was observed in all our cases. The most probable mechanism of growth is considered to be progressive ectasia of the blood vessels or their autonomous development at the edges of the lesion. These lesions appear as an iso/hyperdense mass on nonenhanced CT scans, enhancing intensely with contrast in most cases. Erosion of the sphenoid bone can also be seen occasionally. DSA can be normal and show a relatively avascular mass or a discrete-tomoderate tumoral blush, with feeding vessels originating from branches of the external carotid or cavernous internal carotid. 14, 18, 19 The characteristic DSA finding is lack of tumor blush in arterial and capillary phase and pooling of contrast in the late venous phase, which was seen in all our cases. The ICA is often encircled by the lesion in its cavernous portion, without affecting the diameter. There are reports of successful embolization prior to surgery. 2, 8 In our series, though a prominent inferolateral trunk was seen, as there was no tumor blush, embolization was not attempted. Unlike cerebral cavernous angiomas and their characteristic popcorn appearance, their CS counterparts do not have a pathognomonic appearance on MRI. However, they are well-delimited parasellar lesions, hypo-or isointense in T1-weighted images, and brightly hyperintense in T2-weighted images. A dumbbell-shaped mass can sometimes be seen, with a small suprasellar component and a large CS component. 14, 18, 19 Instead of the dumbbell mass, a nipple-like projection toward the sella was seen in all our cases with large tumors. Enhancement postcontrast is intense and homogeneous. Though the progressive contrast "filling in" in CS lesions on conventional contrast-enhanced sequences is not specific, it is suggestive of the diagnosis of CSH and was seen in one of our cases.
The most important differential diagnosis (and the most common preoperative misdiagnosis) is a parasellar meningioma. Although differentiation between these two conditions could be difficult, a homogeneously enhancing mass enwrapping the ICA without significant reduction in its caliber should lead diagnosis toward a CSH. Other possible differential diagnosis in this context is parasellar schwannoma.
14,18,19

Surgical Management
Because the onset is insidious, these lesions usually attain a large size before the symptoms start. Therefore, surgical excision is the most favored modality for management, considering the benign nature of the pathology and potential curability. Linskey and Sekhar reported the use of a combined intra-and extradural approach to treat three patients with CSH, and they performed total excision with minimal blood loss and preservation of CN function in two patients. 2 They further hypothesized that the tumor arises within the CS and, when small, it takes its blood supply from the intracavernous carotid artery. Goel reported 13 patients with CSH, 7 of whom were operated on using Dolenc technique of an entirely extradural approach. 6 Of these, 12 patients had a complete tumor resection. The CN outcome in their series was poor, perhaps because of the large size of the tumors at diagnosis. Shi et al retrospectively analyzed 10 patients with CSH. 20 Among the 10 patients, total tumor removal was performed in 4 patients, partial removal in 2 patients, and 4 patients had tumor biopsies. Both patients who underwent partial removal developed complete ophthalmoplegia and diminished sensation in the distribution of CN VI after surgery; one patient developed contralateral paralysis. Zhou et al published 20 surgically treated cases of CSH, 13 of which were treated using the extradural approach.
17
Complete tumor removal was achieved in 12 patients, and at a mean follow-up of 3 years, all patients in this group improved without tumor recurrence. patients with CSH over a period of 14 years (1999-2012), 13 of whom were treated using a purely extradural transcavernous surgical approach, whereas 9 were given primary GKRS. Gross total excision was achieved in all but one patient. Transient CN dysfunction was present for 2 to 3 months in all but three patients. One patient developed permanent VI nerve palsy. Vision improved in all patients with preoperative visual diminution but not in those with preoperative complete vision loss. They further opined that because CN VI is the only CN truly within the CS, it will most often run through the substance of the tumor; CNs III, IV, and V (V1, V2, and V3) will always be found stretched over the surface of the tumor in the overlying dura. Because of the presence of the pseudo capsule, there will always be a potential plane between the tumor and the overlying dura and CNs. This can be utilized to preserve CNs III, IV, and V (V1, V2) when removing a hemangioma rather than when removing a CS meningioma that arises from the dura that invests these nerves. We opine that the key to preservation of CNs is opening the superior orbital fissure first and tracing the nerves posteriorly toward the CS. We recommend avoiding disturbing CN III unnecessarily, as it is very sensitive. The space between CN IV and V1 is sufficient to detach the anteromedial aspect of the tumor. Furthermore, as CN VI lies within the substance of the tumor, it is best preserved during the initial part of the surgery. With careful preservation of the nerves, deficits are usually temporary and will improve during follow-up, unless CN palsy was present prior to treatment. Sometimes tumor in the anteromedial part may be densely adhered to the ICA and CN III and may not be removed easily. In this circumstance, subtotal or partial resection is the wise choice, followed by GKRS. In our series, CN deficits were higher, as most of the cases presented late, thereby attaining large sizes with established deficits. Janjua et al 12 reported a separate layer, which they called the intermediate layer, between the outer meningeal layer and inner membranous layer in the lateral wall of the CS in fresh cadaver heads. The meningeal dura and intermediate layer adhered closely to each other at the SOF, making it easier to separate these two layers from the membranous layer. During surgery, we did not encounter any difficulty in stripping the two layers of the dura. In our experience, the key to CSH removal are good exposure through a wide craniotomy with de-roofing of the orbital roof to prevent unnecessary traction, stripping of the two layers of the dura to preserve CNs, early identification of the VI nerve to maintain full range of EOM, avoidance of unnecessary dissection of the III nerve, piecemeal removal of the tumor instead of en block excision, and early devascularization of the tumor. The results of CN dysfunction were higher in our series, as the cases were referred late. In fact, as per available literature, the mean volume of cases in our series was the largest (64.57 cm 3 ). However, all the patients are stable and are relieved of disabling symptoms of headache and V nerve involvement. Following this, there have been several reports of the successful use of GKRS in CSH with significant reduction in volume. 9, 16, 22 , The proposed mechanism is radiation-induced endothelial proliferation, vessel wall hyalinization, and subsequent vessel obliteration in addition to direct cytotoxicity to the tumor cells. Nakamura et al proposed that GKRS should be used as primary therapy in small tumors without risking damage to the optic pathways. 23 In large tumors and those close to the visual pathway, they suggested surgical debulking followed by GKRS for the residual portion. 10 Chou et al used GKRS as both primary and secondary treatment modalities for CSH. The largest size of tumor in which GKRS was used in his series was 23.1 cm 3 and average reduction in volume was 82%. The largest series of CSH treated by GKRS was published by Yamamoto et al. 21 It was a multi-institutional study that included 30 cases, and GKRS was used both as primary and secondary therapy. The mean volume of tumor was 11.5 cm 3 , mean dose used 13.8 Gy, and mean follow-up duration 53 months. They analyzed the dose treatment responses and found that tumor shrinkage is directly proportional to the radiation dose received. They further concluded that a peripheral dose of 14 to 15 Gy is sufficient to control the growth of CSH and that a dose of 10 to 12 Gy is the threshold level for tumor growth control. Yamamoto used staged GKRS in two large cases of CSH and put forward the concept of radiosurgical thrombolisation, further vindicating the hypothesis of Lindsay and Sekhar described previously. 21 Though some of these studies advocate using GKRS as a primary modality even in large tumors and achieved good tumor control, we do not follow this policy. We use GKRS as primary therapy only when volume is amendable and the dose to the optic apparatus does not exceed the safety limits of radiation. In our series, there has been no complication related to GKRS. CN involvement improved in two of our cases and the rest showed no new deficits. The mean decrease in volume in our study was 75%, which was comparable to available literature. This reduction in volume is perhaps unique, as no other tumor treated with GKRS demonstrates a consistent and significant reduction in size.
To the best of our knowledge, along with Bansal et al, ours is the only other study available in literature that studied the results of both surgery and Gamma knife for CSH (►Table 3). We feel that CSH need a tailored approach for proper management, and decisions regarding treatment modality must be individualized. Surgery and radiosurgery are complementary to each other and the choice should be individualized based on the size and radiation risk to optic apparatus. The residual tumor, if small, can be followed up at regular intervals or GKRS can be offered to treat the residue.
Conclusion
Both microsurgical excision and GKRS are effective modalities to treat CSH. Though surgery poses formidable challenges, with proper techniques, most CSH can be excised. Established CN involvement prior to surgery usually does not reverse. Though surgery is the preferred modality in large tumors, GKRS is a safe option for cases with small, residual, or recurrent lesions, and can supplement surgery wherever possible.
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